Dennis Wright
Fortuna: 1 M $ al 31/05/2026
Fortuna: 1 M $ al 31/05/2026
Dennis J.
Wright is currently the Chief Scientific Officer at Clinuvel Pharmaceuticals Ltd. He previously worked as the Manager-Global Pharmacovigilance at Mayne Pharma Ltd. Dr. Wright obtained undergraduate, graduate, and doctorate degrees from The University of Sydney.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 12/08/2025 | 192.312 ( 0,38 % ) | 1 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CLINUVEL PHARMACEUTICALS LIMITED | Director Técnico/Científico/I+D | - |
| Empresas | Cargo | Fin |
|---|---|---|
Mayne Pharma Ltd.
Mayne Pharma Ltd. Pharmaceuticals: OtherHealth Technology Manufactures pharmaceutical products | Consejero General | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Clinuvel Pharmaceuticals Ltd.
Clinuvel Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for patients with genetic, metabolic and life-threatening disorders | Health Technology |
The University of Sydney
The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mayne Pharma Ltd.
Mayne Pharma Ltd. Pharmaceuticals: OtherHealth Technology Manufactures pharmaceutical products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.